DocTIS announces the webinar “Discovery of combination therapies for Immune-Mediated Inflammatory Diseases”

DocTIS announces the "Discovery of combination therapies for Immune-Mediated Inflammatory Diseases" webinar

The DocTIS project, a Horizon Europe-funded initiative, focuses on identifying more effective therapies for immune-mediated inflammatory diseases (IMIDs).

By leveraging well-characterized IMID patients, high-quality biological samples, multi-omics data generation, and systems biology approaches, it seeks to discover combinations of targeted existing drugs that are more efficacious at blocking chronic inflammation than the current single-drug practice.

Ultimately, the project aims to improve the lives of patients with six immune-mediated inflammatory diseases: ulcerative colitis, Crohn’s disease, rheumatoid arthritis, systemic lupus erythematosus, psoriasis, and psoriatic arthritis.

If you are interested to learn more about this ambitious EU-funded project, join us for the public online session that will take place on the 6th of February 2025 at 16:00 CET. Speakers will be:

  • Dr. Sara Marsal: Coordinator and Head of Rheumatology Department, Vall d’Hebron Barcelona Hospital Campus.
  • Dr. Holger Heyn: Single Cell Genomics Group Leader at Centro Nacional de Análisis Genómico, CNAG.
  • Dr. Ernest Choy: Professor and Head of Rheumatology Department at Cardiff University.
  • Dr. Pere Santamaria: Pathogenesis and treatment of Autoimmunity Research Group leader at IDIBAPS.
  • Dr. Maria López Lasanta: Postdoc Rheumatology researcher at VHIR, Vall d’Hebron Barcelona Hospital Campus.
  • Dr. Antonio Julià: Head of Rheumatology Research Group at VHIR, Vall d’Hebron Barcelona Hospital Campus.

Attendees will have the opportunity to ask questions following the event.

Register here: https://attendee.gotowebinar.com/register/8708865911080382048

The DoCTIS project has received funding from the European Union’s H2020 reearch and innovation program under grant agreement 848028.